In line, glutamine blockade in tumor bearing mice suppressed metabolism of cancer cells and supported effector T cells (47) and in combination with anti-PD-L1, inhibition of glutamine metabolism promoted the antitumor efficacy of T cells (48). The gene discussed is CD274; the disease is cancer.